FDA Approved: POSACONAZOLE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)

View source ↗

Summary

FDA approved a supplemental application for posaconazole submitted by Glenmark Pharmaceuticals Inc., USA, under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Fungal Infections
• Oropharyngeal Candidiasis
• Prophylaxis of Invasive Fungal Infections in Immunocompromised Patients

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

SUPPL AP for POSACONAZOLE (POSACONAZOLE)